"STRIDE is a randomized, double-blind, controlled, multi-center Phase III study designed to determine if Stimuvax can extend progression free survival in patients treated with hormonal therapy who have inoperable, locally advanced, recurrent or metastatic breast cancer."
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.